Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-09-10Clinical Trial Update: A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067) [Phase 3]
Phase 3 trial evaluating SCH 697243 for grass pollen–related allergic rhinitis with allergic conjunctivitis, with or without asthma; results…
-
FDA approval · 2013-09-09FDA Approved: ALLERGY RELIEF — Supplemental Application (Prodose, Inc)
FDA approved a supplemental application for ALLERGY RELIEF containing cetirizine hydrochloride, submitted by Prodose, Inc.
-
CLINICAL_TRIALS research · 2013-09-09Clinical Trial Update: PF and FeNO and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic Diseases
A clinical trial update from the Medical University of Lodz evaluating PF and FeNO and clinical characteristics in children being diagnosed …
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: Study of Bronchodilation Effects of Cetirizine [Phase 4]
Phase 4 clinical trial evaluating bronchodilation effects of cetirizine in allergic rhinitis and asthma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: An Efficacy Study of JNJ-39220675 and Pseudoephedrine in Participants With Allergic Rhinitis [Phase 2]
Phase 2 efficacy study evaluating JNJ-39220675 in combination with pseudoephedrine for allergic rhinitis; results were posted in 2013 after …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-08-29FDA Approved: QNASL — Supplemental Application (Teva Respiratory, LLC)
FDA approved a supplemental application for QNASL (beclomethasone dipropionate) by Teva Respiratory, LLC.
-
FDA approval · 2013-08-23FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
The FDA approved a supplemental application for Montelukast Sodium submitted by Accord Healthcare Inc. The snippet does not specify the exac…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis [Phase 3]
This is a Phase 3 open-label trial of GW685698X in pediatric patients with perennial allergic rhinitis. Results were posted in 2013.
-
FDA approval · 2013-08-06FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Montelukast Sodium from Dr. Reddy's Laboratories Limited under an ANDA.
-
FDA approval · 2013-08-06FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Montelukast Sodium submitted by Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: Flixonase Safety in Patients With Allergic Rhinitis (AR)
This clinical trial update reports on the safety of Flixonase (fluticasone propionate nasal spray) in patients with allergic rhinitis and no…
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Effects of Lipoic Acid on Oxidative, Inflammatory and Functional Markers in Asthmatic Patients [NA]
A completed clinical trial assessed the effects of alpha-lipoic acid on oxidative, inflammatory, and functional markers in asthmatic patient…
-
FDA approval · 2013-07-23FDA Approved: CLARINEX — Supplemental Application (Organon LLC)
FDA has approved a supplemental application for CLARINEX (desloratadine) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2013-07-12Clinical Trial Update: PK Comparisons of Bepotastine Besilate 10 mg and Bepotastine Salicylate 9.64 mg [Phase 1]
Phase 1 pharmacokinetic comparison of two Bepotastine formulations in allergic rhinitis and urticaria.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC) [Phase 2, Phase 3]
Clinical trial update reports the Phase 2/3 results for topical ASP-1001 in allergic rhinitis, with study results posted in 2013 after compl…
-
FDA approval · 2013-07-02FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for NASACORT ALLERGY 24HR (triamcinolone acetonide) from Chattem, Inc., indicating an update to …
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: Immunological Comparison of AIT and SCIT Immunotherapy Against Grass Pollen [NA]
This completed clinical trial compared immunological outcomes between allergen immunotherapy (AIT) and subcutaneous immunotherapy (SCIT) for…
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: Nasal Allergen Challenge in Rhinitic Subjects [NA]
Clinical trial update noting completion of a nasal allergen challenge study in rhinitic subjects, including individuals with asthma and alle…
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Study of rBet v1 Tablets [Phase 2]
A Phase 2 trial of rBet v1 tablets for birch pollen–related allergic conditions has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial investigates whether the pollen season influences reactions to subcutaneous allergen immunotherapy in patie…
-
FDA label_change · 2013-06-12FDA Approved: OMNARIS — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for Omnaris (ciclesonide) submitted by Covis Pharma US, Inc., resulting in changes to the produc…
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: Correlation of Nasal Volume, Cross-Sectional Area With Nasalance Scores Measured by Acoustic Rhinometry and Nasometry [Phase 4]
Phase 4 clinical trial evaluating the correlation between nasal volume/c cross-sectional area and nasalance scores in individuals with aller…
-
CLINICAL_TRIALS withdrawal · 2013-06-07Clinical Trial Update: A Pilot Investigation of Ciclesonide When Administered as a Hypotonic Versus an Isotonic Formulation of Ciclesonide Nasal Spray [Phase 4]
This Phase 4 pilot trial comparing hypotonic and isotonic formulations of ciclesonide nasal spray for allergic rhinitis was withdrawn.
-
FDA approval · 2013-06-05FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)
The FDA approved a supplemental application for Claritin (loratadine) submitted by Bayer HealthCare LLC.
-
CLINICAL_TRIALS withdrawal · 2013-06-03Clinical Trial Update: Topical Allstate and Nasal Allergen Challenge [Phase 3]
A Phase 3 trial evaluating topical Allstate and a nasal allergen challenge for allergic rhinitis has been withdrawn.